China Medical Device Market Entry: A Pathway for International Manufacturers

Define the China product

Confirm the intended use, models, configurations, manufacturing sites and claims proposed for China. These details influence classification, dossier scope and the partners required.

Map the registration workstream

Under current NMPA provisions, imported Class II and Class III devices are reviewed for registration, while imported Class I devices are filed. The exact classification and evidence pathway must be confirmed for the specific device.

Choose the local operating model

• Independent regulatory representation and separate distribution
• Distributor-led registration and commercialization
• Local entity or strategic partnership
• Staged assessment before a full market commitment

Protect long-term control

Clarify ownership and access to registration records, data, trademarks, localized materials and partner-change procedures before appointing commercial parties.